胶原酶治疗腰椎间盘突出症是应该放弃,还是继续深入研究?  

Collagenase chemonucleolysis should be given up or in-depth researched?

作　　者：赵森明[1] Zhao Senming(Department of Painology,the Third Hospital of Hebei Medical University,Shijiazhuang City,Hebei Province 050051,China)

机构地区：[1]河北医科大学第三医院疼痛科,石家庄市050051

出　　处：《中华疼痛学杂志》2020年第4期241-242,共2页Chinese Journal Of Painology

摘　　要：胶原酶髓核溶解术治疗腰椎间盘突出症是疼痛科常用的治疗方法,但是其治疗机制和临床效果并没有得到深入研究和科学的评价。Collagenase chemonucleolysis has been effectively used in the treatment of lumbar disc herniation in pain clinic.However its underlying mechanisms and the effectiveness had not been in-depth researched and objectively evaluated.

关 键 词：胶原酶类 治疗结果 腰椎间盘突出症 适应证 机制 

分 类 号：R681.53[医药卫生—骨科学]